مدافینیل

Also known as Provigil®, 2-((diphenylmethyl)sulfinyl)acetamide, Modafinilum, Modafinilo, Modafinil, Moderateafinil, Alertec

یک داروی محرک سیستم اعصاب مرکزی

OverviewAI-generated

Modafinil is a chemical compound with the formula C₁₅H₁₅NO₂S. Its IUPAC name is 2-benzhydrylsulfinylacetamide. The substance has a mass of 273.08235 and a weight of 273.4. It possesses a defined daily dose of 0.3.

Chemical properties include an xlogp value of 1.7 and a topological polar surface area of 79.4. The molecule contains one hydrogen bond donor and three hydrogen bond acceptors, with a charge of 0. The canonical SMILES representation is C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N.

Modafinil is referenced by 1,549 other encyclopedia articles. It has 40,956 social media followers. A search query for modafinil yields 2,378 results.

Synthesized by Vinony from 19 facts across 4 sources: Wikidata, PubMed, PubChem, Vinony graph. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.

Key facts

Drug.image: Modafinil structure.svg
Drug.image_class: skin-invert-image
Drug.width: 215px
Drug.caption: Modafinil skeletal formula
Drug.image2: (S)-Modafinil molecule ball.png
Drug.image_class2: bg-transparent
Drug.width2: 225px
Drug.caption2: Esmodafinil ball-and-stick model
Drug.tradename: Provigil, others
Drug.MedlinePlus: a602016
Drug.DailyMedID: Modafinil
Drug.pregnancy_AU: D
Drug.dependency_liability: Relatively low
Drug.addiction_liability: Low
Drug.routes_of_administration: Oral (tablets)
Drug.ATC_prefix: N06
Drug.ATC_suffix: BA07
Drug.legal_AU: S4

via Wikipedia infobox

Chemical data

Formula: C15H15NO2S
Molecular weight: 273.4 g/mol
IUPAC name: 2-benzhydrylsulfinylacetamide
SMILES: C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
InChIKey: YFGHCGITMMYXAQ-UHFFFAOYSA-N
XLogP: 1.7
Polar surface area: 79.4 Å²
H-bond donors: 1
H-bond acceptors: 3
Formal charge: 0

via PubChem

Drug data · ChEMBL

Max clinical phase: Approved
Molecule type: Small molecule
First approval: 1998
Admin. routes: oral
Indications: attention deficit hyperactivity disorder, cocaine dependence, methamphetamine dependence, brain neoplasm

via ChEMBL · EBI